申请人:Eli Lilly and Company
公开号:US06664274B1
公开(公告)日:2003-12-16
The present invention provides compounds of formula I
and a method of inhibiting the reuptake of serotonin, antagonizing the 5-HT1A receptor and antagonizing the 5-HT2A receptor which comprises administering to a subject in need of such treatment an effective amount of a compound of formula I.
本发明提供了式I的化合物以及一种抑制5-羟色胺再摄取、拮抗5-HT1A受体和拮抗5-HT2A受体的方法,包括向需要此类治疗的受试者施用式I化合物的有效量。